Compass Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Compass Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Compass Therapeutics Inc
Rating: 2.06991675
Author: Trendlyne DVM scores

about

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its...

5.58 0.37 (7.10%)

Near 52W High of $5.86

3.3M

XNAS Volume

XNAS 13 Jan, 2026 4:30 PM (EST)

Board Meeting

The board meeting for Compass Therapeutics Inc is scheduled for today, for the purpose of J.P. Morgan 2026 Healthcare Conference See details

Not Eligible

Expensive Valuation

6.2 / 100

Technically Bullish

76.6 / 100

1Yr Price target upside is 137%

13 analysts

Compass Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Compass Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its...

Near 52W High of $5.86

SWOT Analysis

Compass Therapeutics Inc Live Price Chart